HeartScore
| Suspicion based on history | ||
|---|---|---|
| 1 Slight (0) | Moderate (+1) | High (+2) |
| ECG | ||
| 1 Normal (0) | Nonspecific repolarization (+1) | ST-depression (+2) |
| Age | ||
| 1 ≤ 45 (0) | 45-65 (+1) | ≥ 65 (+2) |
| Risk factors* | ||
| 1 None (0) | 1 to 2 (+1) | ≥ 3 or atherosclerosis (+2) |
| Troponin | ||
| 1 Normal (0) | 1-3×normal (+1) | ≥ 3×normal (+2) |
| Score | ||
| *include high cholesterol, high blood pressure, diabetes, smoking, obesity | ||
HeartScore is a cardiovascular disease risk assessment and management tool developed by the European Society of Cardiology, aimed at supporting clinicians in optimising individual cardiovascular risk reduction.
Scientific background
HeartScore is the interactive version of SCORE - Systematic COronary Risk Evaluation [3] - a cardiovascular disease risk assessment system initiated by the European Society of Cardiology, using data from 12 European cohort studies (N=205,178) covering a wide geographic spread of countries at different levels of cardiovascular risks. The SCORE data contains some 3-million person-years of observation and 7,934 fatal cardiovascular events.
The SCORE risk estimation is based on the following risk factors: gender, age, smoking, systolic blood pressure, total cholesterol, and estimates fatal cardiovascular disease events over a ten-year period.
HeartScore is one of the tools developed to implement the 2007 European guidelines on CVD prevention in clinical practice.[4]
Features
- History and progress management
- Patient list management
- Graphical display: absolute CVD risk
- Graphical display: risk factors contribution to total risk
- Intervention area: European guidelines on CVD Prevention in clinical practice
- Printable advice
Available versions
In addition to two European versions for high/low risk countries, HeartScore now counts 13 national versions. HeartScore Sweden was the first national version to be launched in 2005, followed by versions in Germany, Greece, Poland, Spain, Cyprus, Slovakia, Czech Republic and Turkey. Translated versions now exist in Bosnia and Herzegovina, Russia, Romania and Croatia.
A roll-out plan of additional national versions has been defined for 2009–2010 within the framework of the EuroHeart Programme of the European Commission and according to countries specific requests. Further updates will be produced as knowledge evolves (new cohort studies, risk factors, end points)
Formats
Three formats have been developed to cater for different users’ needs:
- a web-based version, offering graphical display of absolute CVD risk, including relative risk for younger patients, patient data history and progress monitoring
- a downloadable PC version is available since 2008
- a quick calculator
See also
- Framingham Risk Score
- QRISK
- Coronary artery disease
- Framingham Coronary Heart Disease Risk Score Archived 2019-01-14 at the Wayback Machine
References
- ↑ Backus BE, Six AJ, Kelder JC, Bosschaert MA, Mast EG, Mosterd A, et al. (October 2013). "A prospective validation of the HEART score for chest pain patients at the emergency department". International Journal of Cardiology. 168 (3): 2153–8. doi:10.1016/j.ijcard.2013.01.255. PMID 23465250.
- ↑ Six AJ, Backus BE, Kelder JC (June 2008). "Chest pain in the emergency room: value of the HEART score". Netherlands Heart Journal. 16 (6): 191–6. doi:10.1007/BF03086144. PMC 2442661. PMID 18665203.
- ↑ Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project European Heart Journal 2003;24:987-1003
- ↑ European Guidelines on CVD Prevention in clinical practice, European Journal of Cardiovascular Prevention and Rehabilitation (EJCPR) 2007; vol 14 (suppl 2:S1-S113)